MYNEO THERAPEUTICS

A little history

myNEO was founded in 2018 by leading biotech entrepreneurs combining expertise from different academic institutions. Cedric Bogaert, Jan Van Den Berghe, and Wim van Criekinge have since then expanded the team with established domain in antigen discovery experts as well as ambitious talent to further grow the company's innovation and developments.

myNEO offices

To date, myNEO has achieved several pivotal milestones in realizing its vision. These include:

  • Development of state-of-the-art antigen prediction algorithms
  • Discovery of novel, dark antigen targets called camyotopes
  • (Co-)development of novel immunotherapeutics products via strategic collaborations or in-house, leading to 3 separate programs executing successful IND/CTA filings in 2025
  • The publication of high-impact scientific papers
  • ISO and regulatory approval for clinical use of technology
  • Securing valuable intellectual property with multiple patents
  • Receiving several prestigious awards (Most Disruptive Innovator, Forbes 30under30, Rising Star Fast50)
Sofie Pontzeele

Sofie Pontzeele

Executive assistant

Sofie studied Office Management with a focus on languages and has more than 30 years of experience in administrative and supporting roles for companies who are active on an international level. After a long career in the mice industry, she switched to the healthcare industry. Since 2023 she joined the myNEO team to support the management team on the administrative and organizational side. Next to that, she also assists with HR and PR. Sofie is our happiness manager and helps everyone in the team feeling as comfortable and as happy as possible!

View LinkedIn profile